Trial of milnacipran (Savella™) in combination with pregabalin (Lyrica™) for treatment of fibromyalgia – to recruit at 58 US sites

Hundreds of male and female fibromyalgia patients, ages 18 to 70, will be recruited soon at 58 U.S. sites for participation in a major 11-week trial of two differently-acting prescription drugs taken in combination. Formal title: “Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia” – Identifier NCT00797797. (Results will be compared with results for a cohort of patients taking pregabalin only.)

Each of the two drugs – pregabalin (Lyrica™) and milnacipran (Savella™) – has been approved by the FDA for treatment of fibromyalgia symptoms. Savella, just approved on January 14, 2009, will not be widely available in US pharmacies until March.

For more information and to review a list of the 58 trial sites – so far identified only by state/town and zip code – go to the listing for the trial at

To Contact the Trial Coordinators:
Sandra Beaird, PhD
1-800-678-1605 ext 66297

The trial is sponsored by Forest Laboratories.

1 Star2 Stars3 Stars4 Stars5 Stars (2 votes, average: 3.00 out of 5)

Leave a Reply